Find therapies in clinical trials near you – page 8

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Study on IPN10200 for Treating Cervical Dystonia in Adults

Study on IPN10200 for Treating Cervical Dystonia in Adults

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Study comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Study comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis